Axa
SRGA

Axa’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Axa’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,492
Closed -$990K – 1389
2019
Q1 		$990K Buy
5,492
+3,652
+198% +$528K ﹤0.01% 982
2018
Q4 		$204K Buy
+1,840
New +$240K ﹤0.01% 1232
2017
Q1 		– Sell
-1,927
Closed -$188K – 1339
2016
Q4 		$188K Hold
1,927
– – ﹤0.01% 1215
2016
Q3 		$181K Sell
1,927
-100
-5% -$10K ﹤0.01% 1174
2016
Q2 		$218K Hold
2,027
– – ﹤0.01% 1155
2016
Q1 		$243K Sell
2,027
-353
-15% -$37.1K ﹤0.01% 1116
2015
Q4 		$283K Hold
2,380
– – ﹤0.01% 1124
2015
Q3 		$406K Buy
2,380
+250
+12% +$47.9K ﹤0.01% 1088
2015
Q2 		$413K Buy
2,130
+573
+37% +$106K ﹤0.01% 1126
2015
Q1 		$231K Sell
1,557
-26
-2% -$3.96K ﹤0.01% 1231
2014
Q4 		$247K Buy
1,583
+1,360
+610% +$196K ﹤0.01% 1243
2014
Q3 		$32K Buy
+223
New +$32.3K ﹤0.01% 1380

Other funds holding SRGA

PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HC
Hillman Company Pittsburgh, Pennsylvania $257M AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axa's SRGA Position: Q2 2019 in Review

Axa sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2019, closing a stake of 5,492 shares — an estimated $990K sold.

Axa first reported a position in SRGA in Q3 2014 and held it in 12 quarters. The position peaked at $990K in Q1 2019. 106 funds tracked by Wall St. Rank hold SRGA as of Q2 2019.

  • Axa reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Axa sold 5,492 Surgalign Holdings, Inc. Common Stock shares in Q2 2019, an estimated $990K.
  • Axa first reported a position in Surgalign Holdings, Inc. Common Stock in Q3 2014 and held it in 12 quarters.
  • Axa's Surgalign Holdings, Inc. Common Stock position peaked at $990K in Q1 2019.
  • 106 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2019.

Based on Axa's 13F filing for Q2 2019, filed 13 Aug 2019.